Today, I want to take a look at a large cap pharmaceutical stock with a juicy 4% yield. This company has undergone a lot of changes over the past few years. The company has turned from a major growth stock into a dividend stock. The former CEO quit 3 months and the company just hired a new one. The company made a major acquisition a few years ago that has added cash to the

The company in question is Pfizer (PFE). Pfizer just recently increased its dividend 11% to 80 cents per share. This equates to an even 4% yield. Pfizer has room for more dividend increases as the company is likely to double it earnings per share. EPS is expected to come in at $2.24 per share compared to $1.02 per share last year. The current payout rate is just 35% of this year’s earnings. This is below the payouts of most competitors.

Source: FavStocks

Related Articles:

• Three Dividend Stocks With A Perfect Risk Score
• Increasing Dividend Yield Part VI: Time
• Optimizing Your Asset Allocation
• All Investing Involves Risk
• The Most Important Financial Statement